drugset / Trial / NCT00892567

Evaluating the T Cell Response to a Peptide-based Vaccine in Patients With Breast Cancer

NCT00892567 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate T cell responses against a peptide-based vaccine in patients with breast cancer and to determine whether peptide-specific T cells can be found at the site of breast tumors following vaccination.

Timeline

Start
2009-05
Primary completion
2011-12
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject 9 Peptides from Her-2/neu, CEA, & CTA Vaccine 1 ml Subcutaneous

Indications